ICD-10-CM Billable Code

C16.3

Malignant neoplasm of pyloric antrum

Clinical Classification Guidelines

Inclusion Terms

  • Malignant neoplasm of gastric antrum

Medical Intelligence & Overview

Malignant neoplasm of the pyloric antrum, classified under ICD-10 code C16.3, refers to a type of stomach cancer located in the lower part of the stomach called the pyloric antrum. The pyloric antrum is an important area that controls the emptying of stomach contents into the small intestine. When cancer develops here, it can interfere with normal digestion and may spread to other parts of the body. Recognizing the symptoms and understanding the causes and treatment options are essential for managing this serious condition.

Causes & Symptoms

Clinical Causes: Chronic inflammation of the stomach lining (gastritis), often caused by helicobacter pylori infection Dietary factors, including diets high in smoked, salted, or pickled foods Long-term tobacco use Heavy alcohol consumption Family history of stomach cancer Certain genetic conditions and hereditary cancer syndromes Previous stomach surgery or gastric ulcers Environmental exposure to harmful substances or chemicals

Key Symptoms: Persistent indigestion or upset stomach Unexplained weight loss Abdominal pain or discomfort, especially in the upper abdomen Nausea and vomiting, sometimes with blood Loss of appetite Feeling full quickly when eating Fatigue or weakness due to anemia from bleeding Swelling or a mass in the abdomen Dark stools or blood in vomit

Diagnostic & Treatment

Diagnosis Path: Detecting stomach cancer typically involves a combination of medical evaluations including physical examinations, medical history review, and specific diagnostic tests. Common diagnostic procedures include: - Upper gastrointestinal endoscopy: A flexible tube with a camera is inserted through the mouth to view the stomach lining and obtain tissue samples for biopsy. - Biopsy: Small tissue samples taken during endoscopy examined under a microscope to confirm malignancy. - Imaging studies: Such as CT scans, MRI, or PET scans to determine the extent of the cancer and check for spread. - Laboratory tests: Blood tests to assess overall health, detect anemia, and evaluate tumor markers. Early diagnosis significantly increases the chances of successful treatment, making vigilance for symptoms important.

Treatment Protocols: Treatment options depend on the stage of the cancer, overall health, and patient preferences. Common approaches include: - Surgery: The primary treatment, which may involve removing part of the stomach (subtotal gastrectomy) or entire stomach (total gastrectomy). The goal is to remove the tumor and nearby lymph nodes. - Chemotherapy: Uses anticancer drugs to kill cancer cells, often administered before or after surgery. - Radiation therapy: High-energy rays used to destroy cancer cells, typically combined with chemotherapy. - Targeted therapy and immunotherapy: Emerging options that focus on specific molecules involved in cancer growth or boost the immune system. - Supportive care: Managing symptoms and maintaining quality of life through nutritional support, pain management, and treatment of side effects. The multidisciplinary approach involves surgeons, oncologists, radiologists, and other healthcare professionals to develop an individualized treatment plan.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C16.3 a billable ICD-10 code?
Yes, C16.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C16.3?
Clinical documentation must specify the nature of Malignant neoplasm of pyloric antrum and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

pyloric neoplasm malignant antrum